Silence Therapeutics's total assets for Q2 2026 were £106.41M, a decrease of -7.57% from the previous quarter. DE:XRP2 total liabilities were £67.94M for the fiscal quarter, a 3.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.